These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 3149211)

  • 1. In vivo release profiles of leuprolide acetate from microcapsules prepared with polylactic acids or copoly(lactic/glycolic) acids and in vivo degradation of these polymers.
    Ogawa Y; Okada H; Yamamoto M; Shimamoto T
    Chem Pharm Bull (Tokyo); 1988 Jul; 36(7):2576-81. PubMed ID: 3149211
    [No Abstract]   [Full Text] [Related]  

  • 2. Controlled-release of leuprolide acetate from polylactic acid or copoly(lactic/glycolic) acid microcapsules: influence of molecular weight and copolymer ratio of polymer.
    Ogawa Y; Yamamoto M; Takada S; Okada H; Shimamoto T
    Chem Pharm Bull (Tokyo); 1988 Apr; 36(4):1502-7. PubMed ID: 3138032
    [No Abstract]   [Full Text] [Related]  

  • 3. A new technique to efficiently entrap leuprolide acetate into microcapsules of polylactic acid or copoly(lactic/glycolic) acid.
    Ogawa Y; Yamamoto M; Okada H; Yashiki T; Shimamoto T
    Chem Pharm Bull (Tokyo); 1988 Mar; 36(3):1095-103. PubMed ID: 3136939
    [No Abstract]   [Full Text] [Related]  

  • 4. In vivo characteristics of low molecular weight copoly (D,L-lactic acid) formulations with controlled release of LH-RH agonist.
    Asano M; Fukuzaki H; Yoshida M; Kumakura M; Mashimo T; Yuasa H; Imai K; Yamanaka H
    Biomaterials; 1989 Oct; 10(8):569-73. PubMed ID: 2513891
    [TBL] [Abstract][Full Text] [Related]  

  • 5. One-month release injectable microcapsules of a luteinizing hormone-releasing hormone agonist (leuprolide acetate) for treating experimental endometriosis in rats.
    Okada H; Heya T; Ogawa Y; Shimamoto T
    J Pharmacol Exp Ther; 1988 Feb; 244(2):744-50. PubMed ID: 3126294
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hetero-stereocomplexes of D-poly(lactic acid) and the LHRH analogue leuprolide. Application in controlled release.
    Slager J; Domb AJ
    Eur J Pharm Biopharm; 2004 Nov; 58(3):461-9. PubMed ID: 15451519
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Controlled release of LHRH agonist, leuprolide acetate, from microcapsules: serum drug level profiles and pharmacological effects in animals.
    Ogawa Y; Okada H; Heya T; Shimamoto T
    J Pharm Pharmacol; 1989 Jul; 41(7):439-44. PubMed ID: 2570847
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmaceutical manipulation of leuprorelin acetate to improve clinical performance.
    Toguchi H
    J Int Med Res; 1990; 18 Suppl 1():35-41. PubMed ID: 2138986
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Once-a-month injectable microcapsules of leuprorelin acetate].
    Toguchi H; Ogawa Y; Okada H; Yamamoto M
    Yakugaku Zasshi; 1991 Aug; 111(8):397-409. PubMed ID: 1795229
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Control release of prostaglandin E2 from polylactic acid microcapsules, microparticles and modified microparticles.
    Zhou MX; Chang TM
    J Microencapsul; 1988; 5(1):27-36. PubMed ID: 3199299
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Design and development of controlled release of drugs from injectable microcapsules].
    Takada S; Ogawa Y
    Nihon Rinsho; 1998 Mar; 56(3):675-9. PubMed ID: 9549355
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Microencapsulation and controlled release of insulin from polylactic acid microcapsules.
    Lin SY; Ho LT; Chiou HL
    Biomater Med Devices Artif Organs; 1985-1986; 13(3-4):187-201. PubMed ID: 3915873
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of surface active agents on drug release from polylactic acid-hydrocortisone microcapsules.
    Leelarasamee N; Howard SA; Ma JK
    J Microencapsul; 1988; 5(1):37-46. PubMed ID: 3199300
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Microencapsulation using poly(L-lactic acid) IV: Release properties of microcapsules containing phenobarbitone.
    Jalil R; Nixon JR
    J Microencapsul; 1990; 7(1):53-66. PubMed ID: 2308054
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A method for the preparation of polylactic acid microcapsules of controlled particle size and drug loading.
    Leelarasamee N; Howard SA; Malanga CJ; Ma JK
    J Microencapsul; 1988; 5(2):147-57. PubMed ID: 3199303
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preparation of polylactic acid microcapsules containing ciprofloxacin.
    Yu WP; Wong JP; Chang TM
    J Microencapsul; 1998; 15(4):515-23. PubMed ID: 9651872
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phase-sensitive polymer-based controlled delivery systems of leuprolide acetate: in vitro release, biocompatibility, and in vivo absorption in rabbits.
    Singh S; Singh J
    Int J Pharm; 2007 Jan; 328(1):42-8. PubMed ID: 16959451
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The in vivo evaluation of poly(lactic acid) microcapsules of pilocarpine hydrochloride.
    Vidmar V; Pepeljnjak S; Jalsenjak I
    J Microencapsul; 1985; 2(4):289-92. PubMed ID: 3880490
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of polylactic acid microcapsules containing prostaglandin E2 on the survival rates of grade II coma galactosamine induced fulminant hepatic failure rats.
    Zhou MX; Chang TM
    Biomater Artif Cells Artif Organs; 1987; 15(3):549-58. PubMed ID: 3481554
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Poly(lactic acid) microencapsulated oxytetracycline: in vitro and in vivo evaluation.
    Vidmar V; Smolcić-Bubalo A; Jalsenjak I
    J Microencapsul; 1984; 1(2):131-6. PubMed ID: 6336522
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.